Medical device licence · 86534 · Class 2
CARBAMAZEPINE
No longer licensed: cancelled
Licence status Cancelled; first licensed July 5, 2011; ended July 12, 2022. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 86534
- Licence holder
- Roche Diagnostics GmbhMannheim, Germany
- Risk class
- Class II (low to moderate risk)
- Licence type
- Test Kit
- First licensed
- July 5, 2011
- Ended
- July 12, 2022
- Devices covered
- 3
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- CARBAMAZEPINE CARB3 FOR C311 AND C501/502
- CARBAMAZEPINE CARB3 FOR C701/702
- CARBAMAZEPINE II
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.